GRI Bio, Inc. GRI
1.54 USD +0.08 (+5.48%)
At closeNov 3, 2026, 4:24 PM EST
1.61 +0.07 +4.55%
After hours · Nov 3, 4:24 PM ET
1.42 Day range 1.55
1.36 52-week range 64.12
- YTD
- -77.75%
- 1 year
- -96.56%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 11.50 +646.8% upside
Now 1.54
- Target (low)
- 10.00
- Target (mean)
- 11.50
- Target (high)
- 13.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.32 | -0.40 – -0.24 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Next quarter | -0.24 | -0.24 – -0.24 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Current year | -2.83 | -3.04 – -2.62 | 0.00 | 0.0% | 0 | 0.0% | 2 |
| Next year | -0.925 | -0.95 – -0.90 | -2.83 | +67.3% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 9, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Dec 5, 2024 | Ascendiant Capital | Maintained | Buy | Buy |